According to information presented at Family Medicine Forum 2026, various instruments are now available to help family medicine practitioners diagnose dementia in a timely manner and provide optimal management for patients experiencing cognitive decline.
“Most dementia can be managed within primary care, and there are tools and various resources available to support family doctors and primary care teams to do much of that work,” Sid Feldman, MD, told Medscape News Canada.
Feldman is an associate professor and head of the Division of Care of the Elderly at the University of Toronto. He is also chief of family and community medicine at Baycrest Health Sciences in Toronto.
The resources he discussed were developed by the Centre for Effective Practice, a not-for-profit organization. The tool provides clinicians with cognitive, behavioral, mood, functional, and physical assessments alongside information on laboratory investigations.
Clinical Checklists Aid Complex Care Plans
Feldman recommends that doctors employ an appointment checklist during consultations. To illustrate, he highlighted a management strategy designed for a 78-year-old individual who was diagnosed with moderate Alzheimer’s disease 4 years ago and has since displayed wandering, physical aggression, and anxiety.
The recommended plan includes reassessing her antipsychotic prescription and recent behavior changes. Additionally, the process entails verifying whether the targeted symptoms remain under control; if so, the dosage should be reduced by 25%-50% every few weeks until the medication is stopped entirely, followed by setting up a follow-up visit and taking into account the strain her condition places on her partner.
“The aim is to use antipsychotics at the lowest effective dose for the shortest possible time and then reduce and eliminate that as soon as we can,” Feldman told Medscape News Canada.
Antipsychotic prescriptions were in steady decline across Canada until the COVID pandemic, when rates increased, Feldman said. Prescription rates have since come down, although not to pre-COVID levels.
Tool boosts clinician confidence in dementia care
About 5000 people have used the Centre for Effective Practice tool, mostly primary care practitioners but also health administrators, researchers, patients, and caregivers, Feldman said. Almost 90% of clinician users report that the tool improved their confidence in diagnosing dementia, and more than 80% said it improved their confidence in managing behavioral and psychological symptoms.
Certain situations warrant a referral to a specialist, Feldman said. Patients who should be referred include those with early-onset dementia under age 60, patients with very rapidly progressing dementia, and those who have been prescribed one of two antiamyloid agents approved in Canada, namely lecanemab and donanemab, which require sophisticated tests.
Rita McCracken, MD, PhD, commented on the presentation for Medscape News Canada, stating she appreciated the coalescing of an approach to dementia care. McCracken is an assistant professor of family practice at The University of British Columbia in Vancouver, a health services researcher, and a family physician.
“I really like the idea of us developing tools that acknowledge the reality of how primary care is delivered,” McCracken told Medscape News Canada. That reality often means being a solo practitioner, as about 80% of primary care in Canada is provided by solo doctors who do not practice in a team-based environment.
Frequently Asked Questions About Dementia Tools
What does the Centre for Effective Practice tool include?
The tool provides clinicians with cognitive, behavioral, mood, functional, and physical assessments, along with laboratory investigation information, diagnostic criteria, common dementia subtypes, referral strategies, and effective communication guidance.
Who developed the clinical tool?
The resources were developed by the Centre for Effective Practice, a not-for-profit organization, as part of the Knowledge Translation in Primary Care initiative funded by the Ontario Ministry of Health.
When are specialist referrals necessary for dementia patients?
Referrals are recommended for patients with early-onset dementia under age 60, those with very rapidly progressing dementia, and patients prescribed the approved antiamyloid agents lecanemab and donanemab.
How do clinicians measure caregiver stress using these resources?
Doctors can utilize the Zarit Burden Interview and the Kingston Caregiver Stress Scale to assess caregiver burden, alongside education and counseling resources from the Alzheimer Society of Canada.
What are the usage statistics for the clinical tool?
About 5000 people have used the tool, with nearly 90% of clinician users reporting improved diagnostic confidence and over 80% reporting improved confidence in managing behavioral and psychological symptoms.
“It’s not just a prescription that’s going to help somebody live in grace with dementia,” McCracken told Medscape News Canada.
“Often, I look after the rest of the family so I can see when the husband is becoming more distant, and maybe I need to check in with him to see if he might benefit from seeing a counselor or having his kids visit him a bit more often.”
Related reading